331920 — Celemics Balance Sheet
0.000.00%
- KR₩24bn
- KR₩14bn
- KR₩7bn
- 15
- 49
- 28
- 18
Annual balance sheet for Celemics, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 26,021 | 21,051 | 12,920 | 10,786 | 10,046 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1,413 | 1,108 | 1,056 | 743 | 719 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 28,311 | 22,968 | 15,613 | 12,708 | 12,051 |
Net Property, Plant And Equipment | 1,718 | 3,348 | 3,058 | 2,445 | 1,805 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 30,599 | 26,898 | 22,211 | 18,119 | 29,414 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1,143 | 2,025 | 2,645 | 1,649 | 1,971 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 1,242 | 3,512 | 3,622 | 2,236 | 2,230 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 29,357 | 23,386 | 18,589 | 15,882 | 27,184 |
Total Liabilities & Shareholders' Equity | 30,599 | 26,898 | 22,211 | 18,119 | 29,414 |
Total Common Shares Outstanding |